Lyell Immunopharma, Inc (LYEL) Live Share Price, Invest From India

Lyell Immunopharma, Inc Stock Performance

as on January 31, 2026 at 2:29 am IST

Day's Low
Day's High
$23.73
Day's Price Range
$25.05
$24.05
1.33%
Downside
4.16%
Upside
52 Week's Low
52 Week's High
$7.65
52-Week Price Range
$45.00
$24.05
68.19%
Downside
87.11%
Upside

Lyell Immunopharma, Inc share price movements today

Previous Close: $24.81
Open: $24.66
Volume: 775.7K
Day's Low - High: $23.73 - $25.05
52 Week Low - High: $7.65 - $45.00

Lyell Immunopharma, Inc Historical Returns

1 Month Return: -17.18 %
3 Month Return: + 44.06 %
1 Year Return: + 103.29 %
3 Year Return: -65.52 %
5 Year Return: 0 %

Lyell Immunopharma, Inc Stock Fundamentals & Key Indicators

Check Lyell Immunopharma, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$529.0M

EPS (TTM)

-10.6075

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.78

Industry PE ratio

-2.7995689655172415

PEG Ratio

EBITDA

-184.4M

Revenue (TTM)

41.0K

Profit Margin

0.00%

Return On Equity TTM

-75.75%

Lyell Immunopharma, Inc Stock Valuation

Track how Lyell Immunopharma, Inc P/E has moved over time to understand its valuation trends.

Lyell Immunopharma, Inc in the last 5 years

Overview
Trends

Lowest (-132.44x)

December 31, 2022

Industry (-2.80x)

February 2, 2026

Today (-1.78x)

February 2, 2026

Highest (-2.02x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.78x

Lyell Immunopharma, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lyell Immunopharma, Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lyell Immunopharma, Inc	BUY	$529.0M	NA	-1.78	0.00%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	116.21%	33.56	31.35%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	119.45%	1246.03	1.36%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	48.3%	18.28	32.13%

Stock Returns calculator for Lyell Immunopharma, Inc Stock including INR - Dollar returns

The Lyell Immunopharma, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lyell Immunopharma, Inc investment value today

Current value as on today

₹2,09,012

Returns

₹1,09,012

(+109.01%)

Returns from Lyell Immunopharma, Inc Stock

₹1,03,641 (+103.64%)

Dollar Returns*

₹5,371 (+5.37%)

Analyst Recommendation on Lyell Immunopharma, Inc Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Lyell Immunopharma, Inc. Average target price of $29.67

Lyell Immunopharma, Inc Share Price Target

Get share price movements and forecasts by analysts on Lyell Immunopharma, Inc.

What analysts predicted

18.94%UPSIDE

Target Price

$29.67

Current Price

$24.05

Analyzed by

10 Analysts

Target

$29.67

Lyell Immunopharma, Inc target price $29.67, a slight upside of 18.94% compared to current price of $24.05. According to 10 analysts rating.

Lyell Immunopharma, Inc Stock’s Investor Sentiment and Interest

Search interest for Lyell Immunopharma, Inc Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: January 3, 2026 to February 2, 2026

Change:-46% versus previous 30 day period

Lyell Immunopharma, Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	-4	-5	-5	0	0	0	0	0	0	0
Operating Income	-65	-60	-59	-55	-51	-50	-201	-57	-47	-37
EBITDA	-59	-45	-47	-50	-46	-45	-57	-53	-42	-36
Interest Expense	5	-	-	-	-	-	-	-	-	-
Depreciation	5	5	5	5	4	4	5	3	3	2
Income Before Tax	-63	-50	-52	-60	-45	-44	-191	-52	-42	-38
Income Tax Expense	-2	-6	5	4	-	-	-	-	-	-
Net Income	-63	-50	-52	-60	-45	-44	-191	-52	-42	-38
Net Profit Margin	-236629.63%	-203412.00%	-407153.85%	-2022233.33%	-352376.92%	-131126.47%	-1744863.64%	-745642.86%	-533550.00%	-258973.33%

Lyell Immunopharma, Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	7	10	84	0	0
Gross Profit	0	7	10	84	0	0
Operating Income	-102	-211	-214	-187	-247	-358
EBITDA	-100	-215	-201	-169	-226	-200
Interest Expense	-	5	1	-	-	-
Depreciation	1	4	13	18	20	19
Income Before Tax	-129	-204	-250	-183	-234	-342
Income Tax Expense	-8	-5	35	-178	-10	-
Net Income	-129	-204	-250	-183	-234	-342
Net Profit Margin	-19692.09%	-2636.31%	-2349.47%	-216.24%	-180486.15%	-562285.25%

Lyell Immunopharma, Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-50	-52	-60	-45	-44	-191	-52	-42	-38
Operating Cash Flow	-37	-40	-42	-38	-35	-47	-54	-34	-28
Investing Cash Flow	99	-100	21	45	1	53	69	12	3
Financing Cash Flow	0	0	0	0	-	0	0	0	50
Change in Cash	61	-140	-19	7	-33	5	14	-21	24

Lyell Immunopharma, Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-204	-250	-183	-234	-342
Operating Cash Flow	-160	-126	-169	-163	-162
Investing Cash Flow	-273	-121	-11	184	122
Financing Cash Flow	476	401	10	1	1
Change in Cash	42	153	-170	22	-38

Global Institutional Holdings in Lyell Immunopharma, Inc

Funds	Holdings
Almitas Capital LLC	3.02%
Foresite Capital Management V, LLC	2.12%
Takeda Pharmaceutical Co Ltd	0.21%
ARCH VENTURE CORP	9.48%
Vanguard Group Inc	2.3%

See all

Insights on Lyell Immunopharma, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -191.93M → -38.84M (in $), with an average increase of 100.0% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 7.0K → 15.0K (in $), with an average increase of 29.6% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, LYEL has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 33.5% return, outperforming this stock by 99.0%
NEGATIVE IMPACT
Price Dip
In the last 1 month, LYEL stock has moved down by -17.2%

About Lyell Immunopharma, Inc

we are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. while enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers. our goal is nothing less than to develop curative cell-based immunotherapies for any cancer, with a focus on car-ts and solid tumors.

Organisation	Lyell Immunopharma, Inc
Headquarters	201 Haskins Way, South San Francisco, CA, United States, 94080
Industry	Services
CEO	Dr. Lynn Seely M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Lyell Immunopharma, Inc

Name	Title
Dr. Richard D. Klausner M.D.	Founder & Executive Chairman
Mr. Mark A. Meltz J.D.	General Counsel & Corporate Secretary
Ms. Ann Tomlin	Chief Human Resources Officer
Dr. Lynn Seely M.D., Ph.D.	Interim Principal Financial Officer, Principal Executive Officer, President, CEO & Director
Mr. Stephen J. Hill	Chief Operating Officer
Prof. Stanley R. Riddell M.D.	Founder & Scientific Advisor
Dr. Crystal L. Mackall M.D.	Founder & Scientific Advisor
Nellie Dillery	Director of Accounting
Dr. Gary K. Lee Ph.D.	Chief Scientific Officer
Mr. Bryan Selby	Senior Vice President of Clinical Development Operations

FAQs

What is Lyell Immunopharma, Inc share price today?

Lyell Immunopharma, Inc share price today is $24.05 as on January 31, 2026 at 2:29 am IST at the close of the market. Lyell Immunopharma, Inc share today touched a day high of $25.05 and a low of $23.73.

What is the 52 week high and 52 week low for Lyell Immunopharma, Inc share?

Lyell Immunopharma, Inc share touched a 52 week high of $45 on December 22, 2025 and a 52 week low of $7.65 on June 2, 2025. Lyell Immunopharma, Inc stock price today i.e. January 31, 2026 at 2:29 am IST is closed at $24.05,which is 46.56% down from its 52 week high and 214.38% up from its 52 week low.

What is Lyell Immunopharma, Inc's market capitalisation today?

Lyell Immunopharma, Inc market capitalisation is $0.00T as on January 31, 2026 at 2:29 am IST.

How to invest in Lyell Immunopharma, Inc Stock (LYEL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lyell Immunopharma, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lyell Immunopharma, Inc Shares that will get you 0.0624 shares as per Lyell Immunopharma, Inc share price of $24.05 per share as on January 31, 2026 at 2:29 am IST.

What is the minimum amount required to buy Lyell Immunopharma, Inc Stock (LYEL) from India?

Indian investors can start investing in Lyell Immunopharma, Inc (LYEL) shares with as little as ₹91.641 or $1 (as of February 2, 2026 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹916.41 in Lyell Immunopharma, Inc stock (as per the Rupee-Dollar exchange rate as on February 2, 2026 at 10:43 am IST). Based on Lyell Immunopharma, Inc share’s latest price of $24.05 as on January 31, 2026 at 2:29 am IST, you will get 0.4158 shares of Lyell Immunopharma, Inc. Learn more about fractional shares .